5 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... #Tuberculosis #ActiveTB ... Therapy #regimens #medications ... #Guidelines #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI ... inhibitors • Injection drug ... killed - rest LTBI ... Tuberculosis Diagnosis ... Tuberculosis #TB #Diagnosis
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... HIV-AIDS Treating LTBI ... prevent TB disease) Indications ... and molecular diagnostic ... Tuberculosis #TB #IDSA
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI ... inhibitors • Injection drug ... killed - rest LTBI ... Tuberculosis Diagnosis ... Tuberculosis #TB #Diagnosis
Causes of Lactate Elevation, Lactic Acidosis - Differential Diagnosis

The most common causes of hyperlactatemia are usually:
circulation If drugs ... before beginning treatment ... output - Acute pulmonary ... Alcohol • Type B2: Drugs ... - HIV/HAART medications